[go: up one dir, main page]

AU2002327380A1 - Cells and methods for propagating adenoviral vectors - Google Patents

Cells and methods for propagating adenoviral vectors

Info

Publication number
AU2002327380A1
AU2002327380A1 AU2002327380A AU2002327380A AU2002327380A1 AU 2002327380 A1 AU2002327380 A1 AU 2002327380A1 AU 2002327380 A AU2002327380 A AU 2002327380A AU 2002327380 A AU2002327380 A AU 2002327380A AU 2002327380 A1 AU2002327380 A1 AU 2002327380A1
Authority
AU
Australia
Prior art keywords
cells
methods
adenoviral vectors
propagating adenoviral
propagating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002327380A
Other languages
English (en)
Inventor
Douglas E. Brough
Joseph T. Bruder
Jason G. D. Gall
Imre Kovesdi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genvec Inc
Original Assignee
Genvec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/910,828 external-priority patent/US6682929B2/en
Priority claimed from US09/911,011 external-priority patent/US6677156B2/en
Priority claimed from US09/911,020 external-priority patent/US20030040100A1/en
Application filed by Genvec Inc filed Critical Genvec Inc
Publication of AU2002327380A1 publication Critical patent/AU2002327380A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002327380A 2001-07-23 2002-07-22 Cells and methods for propagating adenoviral vectors Abandoned AU2002327380A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US30721201P 2001-07-23 2001-07-23
US09/910,828 US6682929B2 (en) 2001-07-23 2001-07-23 Adenovector complementing cells
US09/910,828 2001-07-23
US09/911,011 US6677156B2 (en) 2001-07-23 2001-07-23 Non-adenoviral gene product-based complementing cells for adenoviral vectors
US09/911,020 2001-07-23
US60/307,212 2001-07-23
US09/911,020 US20030040100A1 (en) 2001-07-23 2001-07-23 Cell for the propagation of adenoviral vectors
US09/911,011 2001-07-23
PCT/US2002/024051 WO2003020879A2 (fr) 2001-07-23 2002-07-22 Cellules et procedes de propagation de vecteurs adenoviraux

Publications (1)

Publication Number Publication Date
AU2002327380A1 true AU2002327380A1 (en) 2003-03-18

Family

ID=27501930

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002327380A Abandoned AU2002327380A1 (en) 2001-07-23 2002-07-22 Cells and methods for propagating adenoviral vectors

Country Status (2)

Country Link
AU (1) AU2002327380A1 (fr)
WO (1) WO2003020879A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1737885A2 (fr) 2004-04-12 2007-01-03 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Méthode pour utiliser les vecteurs adénovirals amener une réponse immunitaire
WO2007027860A2 (fr) 2005-08-31 2007-03-08 Genvec, Inc. Vaccins contre la malaria a base de vecteurs adenoviraux
BRPI0618441B8 (pt) 2005-11-10 2021-07-27 Genvec Inc vetor adenoviral
WO2011047316A1 (fr) 2009-10-16 2011-04-21 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Séquences d'acides nucléiques codant pour des protéines mosaïques extensibles du vih
JP5980117B2 (ja) 2009-11-09 2016-08-31 ジェンヴェック，インコーポレーテッド サルアデノウイルスベクターの増殖方法
WO2011057254A2 (fr) 2009-11-09 2011-05-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Vaccins à base de vecteur adénoviral simien
CN102892429B (zh) 2010-03-17 2016-08-31 康奈尔大学 基于被破坏的腺病毒的抗滥用药物疫苗
WO2012021730A2 (fr) 2010-08-11 2012-02-16 Genvec, Inc. Vaccin contre le virus syncytial respiratoire (vsr)
WO2012083297A2 (fr) 2010-12-17 2012-06-21 Genvec, Inc. Vecteurs adénoviraux avec régions d'hexon modifiées
WO2012088041A1 (fr) 2010-12-20 2012-06-28 Genvec, Inc. Vaccin contre la dengue à base d'un vecteur adénoviral
WO2013052859A2 (fr) 2011-10-05 2013-04-11 Genvec, Inc. Vaccin contre le virus respiratoire syncytial à base d'un vecteur adénoviral
IN2014DN03005A (fr) 2011-10-05 2015-05-08 Genvec Inc
JP6757120B2 (ja) 2011-10-05 2020-09-16 ジェンヴェック エルエルシー アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法
CN103987726B (zh) 2011-10-05 2017-10-03 金维克有限公司 猴(大猩猩)腺病毒或腺病毒载体及其使用方法
EP2809346A1 (fr) 2012-02-02 2014-12-10 GenVec, Inc. Vaccin contre la malaria à base d'un vecteur adénoviral
US9676824B2 (en) 2012-05-29 2017-06-13 Genvec, Inc. Herpes simplex virus vaccine
EP2855669B1 (fr) 2012-05-29 2018-10-10 GenVec, Inc. Vecteurs adénoviraux de sérotype 28 modifiés
US11155832B2 (en) 2016-09-30 2021-10-26 Genvec, Inc. Adenovectors for delivery of therapeutic genetic material into T cells
AU2019231654B2 (en) 2018-03-06 2025-12-11 Precigen, Inc. Human papillomavirus vaccines and uses of the same
AU2019231652B2 (en) 2018-03-06 2025-05-22 Precigen, Inc. Hepatitis B vaccines and uses of the same
US20220403438A1 (en) 2019-10-08 2022-12-22 Trustees Of Boston College Proteins containing multiple, different unnatural amino acids and methods of making and using such proteins
MX2022010936A (es) 2020-03-05 2022-11-16 Neotx Therapeutics Ltd ³métodos y composiciones para el tratamiento del cáncer con células inmunológicas.

Also Published As

Publication number Publication date
WO2003020879A3 (fr) 2003-10-30
WO2003020879A2 (fr) 2003-03-13

Similar Documents

Publication Publication Date Title
AU2002327380A1 (en) Cells and methods for propagating adenoviral vectors
AU1340000A (en) Novel adenoviral vector and methods for making and using the same
AU2002248297A1 (en) Aav2 vectors and methods
AU2001265154A1 (en) Method and composition for targeting an adenoviral vector
AU2003223775A1 (en) Adeno-associated viral vectors and methods for their production from hybrid adenovirus and for their use
AU2002247080A1 (en) Enhanced waveguide and method
AU6529900A (en) Novel cloning methods and vectors
EP1241577A3 (fr) Méthode et agencements pour le traitement amélioré de bandes de parités
AU2002303343A1 (en) Methods and reagents for cell transplantation
AUPR298901A0 (en) Cell suspension preparation technique and device
AU2001257532A1 (en) Adenoviral vectors for tumor specific gene expression and uses thereof
AU2002338616A1 (en) Vector processor architecture and methods performed therein
AU7435500A (en) Adenoviral vectors
AU2002323690A1 (en) Systems and methods for weighing and charging
AU2003268145A1 (en) Methods for propagating adenovirus and virus produced thereby
AU2003224085A1 (en) Waveguide in porous substrates
AU2145300A (en) Adenoviral vectors
AU2002355155A1 (en) Methods for gene disruption and uses thereof
AU2002256274A1 (en) Minimal adenoviral vectors for immunization
AU2002246758A1 (en) Epididymal lipocalin gene and uses thereof
AU2002342536A1 (en) Adenoviral vector system
AU3375500A (en) Adenoviral vectors, proteins and methods for their use
ZA200406947B (en) Stable adenoviral vectors and methods for propagation thereof
AU2002221595A1 (en) Expression cassettes and adenovirus vectors
AU2001280789A1 (en) Non-viral linear dna vectors and methods for using the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase